Xiao-Wei Dou, Yuan-Ke Liang, Hao-Yu Lin, Xiao-Long Wei, Yong-Qu Zhang, Jing-Wen Bai, Chun-Fa Chen, Min Chen, Cai-Wen Du, Yao-Chen Li, Jie Tian, Kwan Man, Zhang GJ#.Notch3 maintains luminal phenotype and suppresses tumorigenesis and metastasis of breast cancer via trans-activating estrogen receptor-α.Theranostics,2017,8.
Yuan-Ke Liang, De Zeng, Ying-Sheng Xiao, Yang Wu, Yan-Xiu Ouyang, Min Chen, Yao-Chen Li, Hao-Yu Lin, Xiao-Long Wei, Yong-Qu Zhang, Frank A.E. Kruyt*, Guo-Jun Zhang*. MCAM/CD146 promotes tamoxifen resistance in breast cancer cells through induction of epithelialemesenchymal transition, decreased ERa expression and AKT activation..Cancer Letters, 2017.
He LF*, Xu HW *, Chen M*, Xian ZR, Wen XF, Chen MN, Du CW, Huang WH, Wu JD, Zhang GJ#. Activated-PAK4 predicts worse prognosis in breast cancer and promotes tumorigenesis through activation of PI3K/AKT signaling.Oncotarget , 2016.
Wei XL, Dou XW, Bai JW, Luo XR, Qiu SQ, Xi DD, Huang WH, Du CW, Man K, Zhang GJ#. ERα inhibits epithelial-mesenchymal transition by suppressing Bmi1 in breast cancer. Oncotarget, 2015, 6(25):21704-17.
Liang SX, Peng X, Li XL, Yang P, Xie LH, Li YC, Du CW, Zhang GJ##. Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin. Oncotarget, 2015, 6(2):1020-1030
Liu J, Shen JX, Hu JL, Huang WH and Zhang GJ#. Significance of interleukin-33 and its related cytokines in patients with breast cancers. Frontiers in Immunology, 2014, 5:141.
Zhang GJ*, Chen TB, Connolly B, Lin SA, Hargreaves R, Vanko A, Bednar B, MacNeil DJ, Sur C, and Williams DL. In vivo optical imaging of LacZ expression using lacZ transgenic mice. Assay and Drug Development Technologies, 2009 Aug, 7(4):391-9.
Zhang GJ*, Chen TB, Hargreaves R, Sur C, Williams Jr DL. Bioluminescence imaging of hollow fibers in living animals: its application in monitoring molecular pathways. Nature Protocols, 2008 May 1, 3(5):891-9.
Zhang GJ*, Chen TB, Bednar B, Connolly BM, Hargreaves R, Sur C, Williams Jr DL. Optical imaging of tumor cells in hollow fibers: evaluation of the antitumor activities of anticancer drugs and target validation. Neoplasia, 2007 Aug, 9(8):652-61.
Wei W, Ayad NG, Wan Y, Zhang GJ, MW Kirschcner, Kaelin Jr WG. Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex. Nature, 2004 Mar 11, 428:194-8.
Olenyuk BZ, Zhang GJ, Klco JM, Nickols NG, Kaelin Jr WG, Dervan PB. Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist. Proceedings of the National Academy of Sciences of the United States of America, 2004 Nov 30, 101(48):16768-73.
Zhang GJ*, Safran M, Wei W, Sorensen E, Lassota P, Shapiro G, Zhelev N, Kaelin Jr WG. Bioluminescent imaging of CDK2 inhibition in vivo. Nature Medicine, 2004 Jun, 10:643-8.